Skip to main content

New data on EndoStim therapy for the treatment of gastro-esophageal reflux disease (GERD) presented at Digestive Disease Week® 2016

EndoStim, Inc., a medical device company, today announced new data were presented on its new neurostimulation therapy for gastroesophageal reflux disease (GERD) at the 2016 Digestive Disease Week (DDW) meeting in San Diego, California. The four presentations included analyses of: one year results of an international multi-center study of EndoStim therapy for refractory GERD; and interim results from EndoStim’s international patient registry.
http://www.prnewswire.com/news-releases/new-data-on-endostim-therapy-for-the-treatment-of-gastro-esophageal-reflux-disease-gerd-presented-at-digestive-disease-week-2016-300276779.htm

No Comments yet!

Your Email address will not be published.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2022 Esophageal Cancer Education Foundation- by domino